Related Experiment Video
Updated: May 30, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Metastatic pancreatic cancer: what can nurses do?
1Sylvester Comprehensive Cancer Center and the Leonard M. Miller School of Medicine, University of Miami, Florida, USA. jmacintyre@med.miami.edu
Abstract:
The median survival of patients with metastatic pancreatic cancer is three to six months, making the diagnosis difficult to accept for patients, family, and healthcare providers. Therapeutic options are improving, but the treatment of advanced disease remains palliative. For oncology nurses, understanding the therapeutic and palliative options can provide these patients and their caregivers with additional information to make appropriate and individualized healthcare decisions.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peritoneal Dialysis III: Nursing Management
Peripheral Artery Disease IV: Nursing Management
Kidney Transplant III: Nursing Management
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...